These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26027324)

  • 1. [The immunological characteristics of tonsil mesenchymal stem cells].
    Ding G; Wei L; Sun W; Zhang L
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Jan; 31(1):43-8. PubMed ID: 26027324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
    Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
    J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells do not suppress lymphoblastic leukemic cell line proliferation.
    Mousavi Niri N; Jaberipour M; Razmkhah M; Ghaderi A; Habibagahi M
    Iran J Immunol; 2009 Dec; 6(4):186-94. PubMed ID: 20054106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Effect of IL1β Priming Tonsil Derived-Mesenchymal Stem Cells in Osteoporosis.
    Yoo M; Cho S; Shin S; Kim JM; Park HG; Cho S; Hwang YK; Park DH
    Tissue Eng Regen Med; 2021 Oct; 18(5):851-862. PubMed ID: 34115339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of human mesenchymal stromal cells with peripheral blood mononuclear cells in a Mitogenic proliferation assay.
    Herzig MC; Christy BA; Montgomery RK; Delavan CP; Jensen KJ; Lovelace SE; Cantu C; Salgado CL; Cap AP; Bynum JA
    J Immunol Methods; 2021 May; 492():113000. PubMed ID: 33609532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of menstrual blood-derived stromal stem cells on proliferative capacity of peripheral blood mononuclear cells in allogeneic mixed lymphocyte reaction.
    Nikoo S; Ebtekar M; Jeddi-Tehrani M; Shervin A; Bozorgmehr M; Kazemnejad S; Zarnani AH
    J Obstet Gynaecol Res; 2012 May; 38(5):804-9. PubMed ID: 22436017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human regulatory macrophages are potent in suppression of the xenoimmune response via indoleamine-2,3-dioxygenase-involved mechanism(s).
    Guo F; Hu M; Huang D; Zhao Y; Heng B; Guillemin G; Lim CK; Hawthorne WJ; Yi S
    Xenotransplantation; 2017 Sep; 24(5):. PubMed ID: 28771838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune properties of human umbilical cord Wharton's jelly-derived cells.
    Weiss ML; Anderson C; Medicetty S; Seshareddy KB; Weiss RJ; VanderWerff I; Troyer D; McIntosh KR
    Stem Cells; 2008 Nov; 26(11):2865-74. PubMed ID: 18703664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO.
    Tipnis S; Viswanathan C; Majumdar AS
    Immunol Cell Biol; 2010; 88(8):795-806. PubMed ID: 20386557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tonsil-derived mesenchymal stem cells exert immunosuppressive effects on T cells.
    Bačić A; Prgomet D; Janjanin S
    Croat Med J; 2019 Feb; 60(1):12-19. PubMed ID: 30825273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of Biological Characteristics and Immunosuppressive Activity between Human Amniotic Mesenchymal Stem Cells and Human Bone Marrow Mesenchymal Stem Cells].
    Hong JQ; Gao Y; Song J; Zhuo WB; Sun HT; Ping BH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):858-64. PubMed ID: 27342523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [IMMUNOGENICITY OF HUMAN UMBILICAL CORD BLOOD DERIVED MESENCHYMAL STEM CELLS AFTER OSTEOGENIC INDUCTION].
    Yang D; Lin H; Liu G
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Jun; 28(6):752-7. PubMed ID: 26455231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.
    Klyushnenkova E; Mosca JD; Zernetkina V; Majumdar MK; Beggs KJ; Simonetti DW; Deans RJ; McIntosh KR
    J Biomed Sci; 2005; 12(1):47-57. PubMed ID: 15864738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells.
    Trivedi P; Hematti P
    Exp Hematol; 2008 Mar; 36(3):350-9. PubMed ID: 18179856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human tonsil‑derived mesenchymal stromal cells enhanced myelopoiesis in a mouse model of allogeneic bone marrow transplantation.
    Ryu JH; Park M; Kim BK; Kim YH; Woo SY; Ryu KH
    Mol Med Rep; 2016 Oct; 14(4):3045-51. PubMed ID: 27511380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell co-culture and mixed lymphocyte reaction systems.
    Demircan PC; Sariboyaci AE; Unal ZS; Gacar G; Subasi C; Karaoz E
    Cytotherapy; 2011 Nov; 13(10):1205-20. PubMed ID: 21905956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of genes involved in immune response and in vitro immunosuppressive effect of equine MSCs.
    Remacha AR; Barrachina L; Álvarez-Arguedas S; Ranera B; Romero A; Vázquez FJ; Zaragoza P; Yañez R; Martín-Burriel I; Rodellar C
    Vet Immunol Immunopathol; 2015 Jun; 165(3-4):107-18. PubMed ID: 25977164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of HLA-G and Related Immunosuppressive Effects in Human Umbilical Cord Stroma-Derived Stem Cells.
    Ding DC; Chou HL; Chang YH; Hung WT; Liu HW; Chu TY
    Cell Transplant; 2016; 25(2):217-28. PubMed ID: 26044082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential.
    Rizzo R; Lanzoni G; Stignani M; Campioni D; Alviano F; Ricci F; Tazzari PL; Melchiorri L; Scalinci SZ; Cuneo A; Bonsi L; Lanza F; Bagnara GP; Baricordi OR
    Cytotherapy; 2011 May; 13(5):523-7. PubMed ID: 21171826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.